BPMUF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Basilea Pharmaceutica AG (BPMUF) Ownership - Who owns Basilea Pharmaceutica AG?

Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializingÂ drugs to meet the needs of patients with severe bacterial and fungal infections... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

Hegenheimermattweg 167b

Phone

+41 616061111

Employees

147

Web

https://www.basilea.com

Details

Group

Domestic Stock Funds

Fundamentals

BPMUF

Capitalization

570M

P/E Ratio

7.83

Risk (Beta)

0.22

Dividend Yield

N/A

Total Cash

63M

Total Cash/Share

5.19

Total Debt

112M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

17.79%

Revenue

149M

ROE

N/A

Book Value

16.8M

P/B Ratio

6.84

Cash Flow

N/A

Earnings

-0.07

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

13.2M

Current Ratio

4.10

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-4.5M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-0.31

Shares Held By Institutions

137M

Shares Outstanding - Current

12.1M

Total Liabilities

172M

Total Volume MTD

N/A

Value

-1

Gain YTD

2.215

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology